Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyojin Ko

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in miceWon-Il Jeong, Ogyi Park, Yang-Gun Suh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2026
Millimeter-Scale Dual-Opposing RNA-Gradient Hydrogel for Interfacial Gene SilencingTyler Hoffman, Cong Truc Huynh, Marcus J Goudie, et al.
Advanced Drug Delivery Reviews|June 10, 2019
Electrically conductive nanomaterials for cardiac tissue engineeringKhadijeh Ashtari, Hojjatollah Nazari, Hyojin Ko, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsHyojin Ko, Rhonda L Carter, Liesbet Cosyn, et al.
Bioorganic & Medicinal Chemistry|August 25, 2016
The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3Sun-Mi Lee, Kyoung Bin Yoon, Hyo Jeong Lee, et al.
Bioorganic & Medicinal Chemistry|June 9, 2009
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucoseHyojin Ko, Arijit Das, Rhonda L Carter, et al.
Journal of Medicinal Chemistry|January 20, 2015
Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62Jin-Hee Park, Ga-Eun Lee, So-Deok Lee, et al.
Journal of Medicinal Chemistry|July 19, 2016
Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and InvasionJin-Hee Park, Darren R Williams, Ji-Hyung Lee, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|September 18, 2009
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptorRhonda L Carter, Ingrid P Fricks, Matthew O Barrett, et al.
Journal of Medicinal Chemistry|May 8, 2010
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsHiroshi Maruoka, Matthew O Barrett, Hyojin Ko, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in miceWon-Il Jeong, Ogyi Park, Yang-Gun Suh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2026
Millimeter-Scale Dual-Opposing RNA-Gradient Hydrogel for Interfacial Gene SilencingTyler Hoffman, Cong Truc Huynh, Marcus J Goudie, et al.
Advanced Drug Delivery Reviews|June 10, 2019
Electrically conductive nanomaterials for cardiac tissue engineeringKhadijeh Ashtari, Hojjatollah Nazari, Hyojin Ko, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsHyojin Ko, Rhonda L Carter, Liesbet Cosyn, et al.
Bioorganic & Medicinal Chemistry|August 25, 2016
The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3Sun-Mi Lee, Kyoung Bin Yoon, Hyo Jeong Lee, et al.
Bioorganic & Medicinal Chemistry|June 9, 2009
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucoseHyojin Ko, Arijit Das, Rhonda L Carter, et al.
Journal of Medicinal Chemistry|January 20, 2015
Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62Jin-Hee Park, Ga-Eun Lee, So-Deok Lee, et al.
Journal of Medicinal Chemistry|July 19, 2016
Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and InvasionJin-Hee Park, Darren R Williams, Ji-Hyung Lee, et al.
Pageof 6